Lifitegrast for dry eye disease
NIHR HSRIC
Record ID 32016001002
English
Authors' objectives:
Lifitegrast is a new drug to treat the signs and symptoms of dry eye disease. Dry eye disease occurs when the eyes do not make tears properly, the tears are not of the correct consistency, or tears evaporate too quickly. This leads to inflammation in the front surface of the eye, and discomfort or problems with vision. Lifitegrast is taken as an eye drop and prevents inflammation of the eye.
Lifitegrast for dry eye disease
NIHR HSRIC ID: 6581
This
Details
Project Status:
Completed
URL for project:
http://www.hsric.nihr.ac.uk/topics/lifitegrast-for-dry-eye-disease/
Year Published:
2016
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Dry Eye Syndromes
- Humans
- Keratoconjunctivitis Sicca
- Phenylalanine
- Sulfones
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.